Literature DB >> 4395067

Antagonism by amantadine of prochlorpemazine-induced catalepsy.

P Simon, J Malatray, J R Boissier.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4395067     DOI: 10.1111/j.2042-7158.1970.tb10567.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  12 in total

1.  Potentiation of central effects of L-dopa by an inhibitor of catechol-O-methyltransferase.

Authors:  J Nuutila; S Kaakkola; P T Männistö
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

2.  The role of dopamine in pilocarpine-induced catalepsy.

Authors:  L Ahtee; I Kääriäinen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

3.  The effect of anti-Parkinson drugs on catalepsy induced by -methyl-p-tyrosine in rats pretreated with intraventricular 6-hydroxydopamine.

Authors:  C H Cashin; S Sutton
Journal:  Br J Pharmacol       Date:  1973-03       Impact factor: 8.739

4.  Possible neuronal mechanisms involved in neurotensin-induced catalepsy in mice.

Authors:  K Shibata; K Yamada; T Furukawa
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  Inhibition by apomorphine of the metoclopramide-induced catalepsy and increase in striatal homovanillic acid content.

Authors:  L Ahtee
Journal:  Br J Pharmacol       Date:  1975-11       Impact factor: 8.739

6.  Amantadine antagonism of oxotremorine effects.

Authors:  Y Eshel; A D Korczyn
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

7.  Production of catalepsy and depletion of brain monoamines by a butyrophenone derivative.

Authors:  L D Fuenmayor; M Vogt
Journal:  Br J Pharmacol       Date:  1979-09       Impact factor: 8.739

8.  Amantadine-HCl (Symmetrel) in the management of Parkinson's disease: a double-blind cross-over study.

Authors:  A Barbeau; H Mars; M I Botez; M Joubert
Journal:  Can Med Assoc J       Date:  1971-07-10       Impact factor: 8.262

9.  Effect of muscarinic cholinergic drugs on morphine-induced catalepsy, antinociception and changes in brain dopamine metabolism.

Authors:  S Kaakkola; L Ahtee
Journal:  Psychopharmacology (Berl)       Date:  1977-03-23       Impact factor: 4.530

10.  Effect of muscimol, a central GABA receptor agonist, on the catalepsy, striatal homovanillic acid increase, and analgesia induced by pilocarpine in rats.

Authors:  S R Naik; M R Kelkar; S R Amladi; U K Sheth
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.